Skip to main content

Home/ Vitamin D/ Group items tagged researc

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies -- T... - 0 views

cancerres.aacrjournals.org/...1885

2009 March study researc epidemiological review mata-analysis vitamin_D receptor VDR polymorphism genetics genotype ovarian cancer risk ovarian_cancer

shared by Matti Narkia on 25 Aug 09 - Cached
  • Matti Narkia on 25 Aug 09
     
    Our results of an association with the Fok1 VDR polymorphism further support a role of the vitamin D pathway in ovarian carcinogenesis. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE. Cancer Res. 2009 Mar 1;69(5):1885-91. Epub 2009 Feb 17. Erratum in: Cancer Res. 2009 Jun 15;69(12):5267. Gate, Margaret A [corrected to Gates, Margaret A]. PMID: 19223536 doi: 10.1158/0008-5472.CAN-08-3515
Matti Narkia

Vitamin D fortification as public health policy: significant improvement in vitamin D s... - 0 views

www.nature.com/...1602414a.html

2006 August ejcn study researc epidemiological young Finnish men Finland Tuohimaa Laaksi vitamin_D fortification 25ohd status improvement insufficiency deficiency nutrition winter wintertime milk medline

shared by Matti Narkia on 22 Sep 09 - Cached
  • Matti Narkia on 22 Sep 09
     
    Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men. Laaksi IT, Ruohola JP, Ylikomi TJ, Auvinen A, Haataja RI, Pihlajamäki HK, Tuohimaa PJ. Eur J Clin Nutr. 2006 Aug;60(8):1035-8. Epub 2006 Feb 15. PMID: 16482069
Matti Narkia

Serum 25-hydroxyvitamin D and the risk of ovarian cancer - ScienceDirect - European Jou... - 0 views

www.sciencedirect.com/science

2009 August study researc epidemiological humans women Finnish Finland vitamin_D 25ohd calcidiol ovarian cancer ovarian_cancer risk nutrition medline Tuohimaa

shared by Matti Narkia on 16 Dec 09 - Cached
  • Matti Narkia on 16 Dec 09
     
    Serum 25-hydroxyvitamin D and the risk of ovarian cancer. Toriola AT, Surcel HM, Agborsangaya C, Grankvist K, Tuohimaa P, Toniolo P, Lukanova A, Pukkala E, Lehtinen M. Eur J Cancer. 2009 Aug 25. [Epub ahead of print] PMID: 19713101 doi:10.1016/j.ejca.2009.08.002 Conclusion Overall, we did not observe a significant association between serum 25-OHD concentrations and the risk of ovarian cancer. However, we found evidence suggestive of an increased risk among women with low to insufficient serum 25-OHD concentrations.
1 - 3 of 3
Showing 20▼ items per page